OpenAI provided the first detailed explanation of the Hugging Face incident at the annual cybersecurity conference in Las Vegas.
Data
Overview of EU AI Act transparency obligations under Art 50, and guidance for legal and compliance counsel.
Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.
Changes in the surveillance function were the focus of one discussion at XLOD Global.
Our regular look at notable regulatory and compliance developments in the region.
This panel discussion at XLOD Global 2026 focused on how regulatory pressure has moved the dial on resilience.
There are several compliance challenges for firms incorporating AI notetaking into their processes.
Discussion on this panel at XLOD Global centered on interpreting and implementing evolving expectations on non-financial risk.